---
title: "新型双效抗生素对抗细菌耐药性"
description: "新型双效抗生素对抗细菌耐药性"

---


:::info

“智闻AI“ 是由人工智能编撰的刊物集合，确保您只获得最有价值的信息，旨在助您消除信息差，突破信息茧房的局限。  [了解更多 >>](/)

:::

# 新型双效抗生素对抗细菌耐药性

import Tabs from '@theme/Tabs';
import TabItem from '@theme/TabItem';

<Tabs
	defaultValue="summary"
	values={[
	{label: 'summary', value: 'summary'},
	{label: 'score', value: 'score'},
]}>
<TabItem value="summary">


新型抗生素“麦克罗酮”（macrolones）能两次打击细菌，既阻断蛋白质生产，又干扰DNA。细菌无法同时防御这两方面，因此更难抵抗。这种药物结合了红霉素（erythromycin）和环丙沙星（ciprofloxacin）的成分。科学家表示，可以通过调整使其更有效地同时攻击这两个目标。

麦克罗酮：合成药物，混合两种抗生素类型。红霉素阻止蛋白质的生成，而环丙沙星则针对细菌中的DNA促旋酶（DNA gyrase），这是一种酶。
</TabItem>
<TabItem value="score">
	| Scores     | Value   | Explanation |
	| -------- | ------- | ------- |
	| Objectivity  | 6    | Balanced reporting with comprehensive analysis.    |
	| Social Impact | 5     | Significant influence on public opinion in health sector.    |
	| Credibility    | 5    | Solid evidence from authoritative sources.    |
	| Potential    | 6    | High potential to lead to significant health changes.    |
	| Practicality    | 5    | Extremely practical, widely applicable in health practice.    |
	| Entertainment Value    | 2    | Somewhat monotonous, few entertaining elements.    |
</TabItem>
</Tabs>

[Full article>>](https://science.slashdot.org/story/24/08/04/0252222/revolutionary-dual-action-antibiotic-makes-bacterial-resistance-nearly-impossible?utm_source=rss1.0mainlinkanon&utm_medium=feed)
